In studies on myocytes from CPVT mice, inhibition of proarrhythmic Ca2+ waves was initially attributed to a novel action on the type-2 ryanodine receptor (RyR2). The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.